New Eye lash growth drug
Forget False Eyelashes, these New products that lengthen eyelashes are based on the eyelash growth side effect of drugs from the prostaglandin family.
Specifically, Eyelash growth is a side effect of a glaucoma drug called Lumigan, sold by Botox maker Allergan Inc.
Cosmetics companies are creating new eyelash treatments that contain either
bimatoprost, the active ingredient in Lumigan, or other prostaglandins found in
The eyelash applications come in tubes and have a brush or tip for applying
the product along the base of the lashes.
PhotoMedex Inc. has created MD Lash Factor
Allergan has filed a patent infringement suit against seven eyelash-product companies including Jan Marini Skin Research, Athena Cosmetics and PhotoMedex.
The side effects of longer eyelash growth from the prostaglandin family of drugs has been described in the medical literature for years.
According to an expert, Women seeking longer and thicker eyelashes can use: